CHARLES SCHWAB INVESTMENT MANAGEMENT INC
Position in TBPH — Theravance Biopharma, Inc.
CIK 884546
SAN FRANCISCO, CA
Position in TBPH
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$5,040,940
-$820,790 QoQ
Shares Held
310,594
-0.9% QoQ
Ownership
0.602%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TBPH Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $5,925,726,276 across 288 Biotechnology names. TBPH ranks #122 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,920,871 | $857,745,736 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
804,508 | $621,595,061 | |
| 3 | MRNA |
Moderna, Inc.
|
4,734,356 | $240,505,284 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
673,356 | $222,793,299 | |
| 5 | INSM |
INSMED Inc
|
1,069,390 | $174,866,652 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
1,735,476 | $168,775,041 | |
| 7 | INCY |
Incyte Corp
|
1,729,102 | $162,743,080 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
1,976,094 | $146,744,740 |
All Filings in TBPH
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $5,040,940 | 310,594 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $5,861,730 | 313,294 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $4,674,102 | 320,144 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $3,351,873 | 303,887 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $2,569,303 | 287,716 | Shares | Sole | 2025-09-15 | |
| 2024-12-31 | $2,765,937 | 293,936 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $2,352,520 | 291,876 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $2,469,935 | 291,266 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $2,785,193 | 310,501 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $3,529,483 | 314,011 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $2,832,167 | 328,177 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $4,175,800 | 403,459 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $5,239,161 | 482,872 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $5,793,873 | 516,388 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $5,322,648 | 524,916 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $4,561,501 | 503,477 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $3,849,238 | 402,640 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $4,315,522 | 390,545 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $2,603,268 | 351,793 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $5,177,018 | 356,544 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $6,806,408 | 333,484 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $5,749,981 | 323,578 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $4,636,043 | 313,564 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $6,595,267 | 314,210 | Shares | Sole | 2020-08-20 | |
| 2020-03-31 | $6,923,201 | 299,576 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||